Mirtazapine contains not less than 99.0% and not more than 101.0% of C17H19N3, calculated on dried substance.

共有 1 個藥物證書使用此成份

米達紗賓
Mirtazapine

• 申請商: 新雙隆生技股份有限公司
• 適應症: 治療憂鬱藥
• 發證日期: 2020-02-20